Pharmacy- Page 26

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Merck & Co Inc. Bottom Line Drops 2% In Q1

The FINANCIAL -- Merck known as MSD outside the United States and Canada, on May 2 announced financial results for the first quarter of 2017.

by The FINANCIAL

May 2, 2017

6 mins read

Pharmacy

AbbVie stock surges 1.5% after first-quarter profit, revenue beats

The FINANCIAL -- AbbVie announced financial results for the first quarter ended March 31, 2017.

by The FINANCIAL

April 27, 2017

4 mins read

Pharmacy

Bristol-Myers Squibb Co. Reveals 13% Rise In Q1 Bottom Line

The FINANCIAL -- Bristol-Myers Squibb Company on April 27 reported results for the first quarter of 2017, which were highlighted by strong sales for key products Opdivo and Eliquis , regulatory approval for Opdivo in advanced bladder cancer in the U.S., positive

by The FINANCIAL

April 27, 2017

7 mins read

Pharmacy

Roche Q1 sales beat expectations, helped by rising Tecentriq revenue

The FINANCIAL -- Commenting on the Group’s results, Roche CEO Severin Schwan said: «We have started the year with good growth in both our Pharmaceuticals and Diagnostics Divisions and with important positive clinical study results. A highlight of the first quarter was

by The FINANCIAL

April 27, 2017

3 mins read

Pharmacy

Bayer Q1 Profit Rises On Strong Sales

The FINANCIAL -- The Bayer Group got off to a very successful start to 2017 and generated strong sales and earnings growth in the first quarter. “At Pharmaceuticals, we once again benefited from the very good performance of our key growth products,”

by The FINANCIAL

April 27, 2017

6 mins read

Pharmacy

Biogen Reports First Quarter 2017 Revenues of $2.8 Billion

The FINANCIAL -- Biogen Inc. on Aptil 25 reported first quarter 2017 financial results, including:

by The FINANCIAL

April 25, 2017

4 mins read

Pharmacy

Allergan Granted Marketing Authorization by the FDA for TrueTear

The FINANCIAL -- Allergan plc, on April 25 announced that it has been granted marketing authorization from the U.S. Food and Drug Administration (FDA) for TrueTear Intranasal Tear Neurostimulator, the first and only FDA-cleared device developed to temporarily increase tear production during

by The FINANCIAL

April 25, 2017

1 min read

Pharmacy

Eli Lilly And Co. Announces 18% Increase In Q1 Profit

The FINANCIAL -- Eli Lilly and Company on April 25 announced financial results for the first quarter of 2017.

by The FINANCIAL

April 25, 2017

10 mins read

Pharmacy

Abbott sales, profit propped up by St. Jude acquisition

The FINANCIAL -- Abbott on April 19 announced financial results for the first quarter ended March 31, 2017.

by The FINANCIAL

April 19, 2017

5 mins read

Pharmacy

J&J revenue misses on lower-than-expected pharmaceutical sales

The FINANCIAL -- Johnson & Johnson on April 18 announced sales of $17.8 billion for the first quarter of 2017, an increase of 1.6% as compared to the first quarter of 2016.

by The FINANCIAL

April 18, 2017

4 mins read